Prot #JCAR017-FOL-001: A Phase 2, Open-Label, Single-Arm, Multicohort, Multicenter Trial to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects with Relapsed or Refractory Indolent B-Cell Non-Hodgkin Lymphoma (NHL) (Transcend FL)

Project: Research project

Project Details

StatusActive
Effective start/end date7/27/20 → 7/27/23

Funding

  • ICON Clinical Research, LLC (Prot #JCAR017-FOL-001)
  • Celgene Corporation (Prot #JCAR017-FOL-001)